174 related articles for article (PubMed ID: 36789476)
1. CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium.
Lee S; Kim Y; Kim YS; Zhang H; Noh M; Kwon YG
Allergy; 2023 May; 78(5):1333-1346. PubMed ID: 36789476
[TBL] [Abstract][Full Text] [Related]
2. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
3. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).
Wedner HJ
Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema.
Qiu T; Chiuchiolo MJ; Whaley AS; Russo AR; Sondhi D; Kaminsky SM; Crystal RG; Pagovich OE
Allergy; 2019 Jun; 74(6):1081-1089. PubMed ID: 30059156
[TBL] [Abstract][Full Text] [Related]
6. HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL; Christiansen SC
Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
[TBL] [Abstract][Full Text] [Related]
7. Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process.
Hofman ZL; Relan A; Zeerleder S; Drouet C; Zuraw B; Hack CE
J Allergy Clin Immunol; 2016 Aug; 138(2):359-66. PubMed ID: 27246526
[TBL] [Abstract][Full Text] [Related]
8. A novel murine in vivo model for acute hereditary angioedema attacks.
Bupp S; Whittaker M; Lehtimaki M; Park J; Dement-Brown J; Zhou ZH; Kozlowski S
Sci Rep; 2021 Aug; 11(1):15924. PubMed ID: 34354123
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema.
Bindke G; Gehring M; Wieczorek D; Kapp A; Buhl T; Wedi B
Allergy; 2022 Mar; 77(3):946-955. PubMed ID: 34287950
[TBL] [Abstract][Full Text] [Related]
10. Roles of Immune Cells in Hereditary Angioedema.
Ferrara AL; Cristinziano L; Petraroli A; Bova M; Gigliotti MC; Marcella S; Modestino L; Varricchi G; Braile M; Galdiero MR; Spadaro G; Loffredo S
Clin Rev Allergy Immunol; 2021 Jun; 60(3):369-382. PubMed ID: 34050913
[TBL] [Abstract][Full Text] [Related]
11. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
12. An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema.
Liu J; Qin J; Borodovsky A; Racie T; Castoreno A; Schlegel M; Maier MA; Zimmerman T; Fitzgerald K; Butler J; Akinc A
RNA; 2019 Feb; 25(2):255-263. PubMed ID: 30463937
[TBL] [Abstract][Full Text] [Related]
13. Definition and classification of hereditary angioedema.
Proper SP; Lavery WJ; Bernstein JA
Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S03-S07. PubMed ID: 33109317
[TBL] [Abstract][Full Text] [Related]
14. The role of the complement system in hereditary angioedema.
Csuka D; Veszeli N; Varga L; Prohászka Z; Farkas H
Mol Immunol; 2017 Sep; 89():59-68. PubMed ID: 28595743
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency.
Obtułowicz K; Góralska J; Bogdali A; Dyga W; Obtułowicz A; Myszkowska D; Ziemianin M; Gruca A; Solnica B; Czarnobilska E
Pol Arch Intern Med; 2020 Feb; 130(2):79-88. PubMed ID: 31933486
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary angioedema].
Bouchard LJ; Hyry H; Meri S
Duodecim; 2012; 128(24):2547-54. PubMed ID: 23393928
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
[TBL] [Abstract][Full Text] [Related]
18. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary angioedema: new mechanisms and therapeutic options].
Reshef A; Leibovich I; Goren A; Kidon M
Harefuah; 2009 Aug; 148(8):529-34, 571. PubMed ID: 19899257
[TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
Davis AE
Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S7-12. PubMed ID: 18220146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
